Cardiac mitochondria in heart failure: normal cardiolipin profile and increased threonine phosphorylation of complex IV.
暂无分享,去创建一个
[1] C. Hoppel,et al. Cardiolipin: characterization of distinct oxidized molecular species , 2011, Journal of Lipid Research.
[2] C. Hoppel,et al. Mitochondria in heart failure. , 2010, Cardiovascular research.
[3] C. Hoppel,et al. Separation and characterization of cardiolipin molecular species by reverse-phase ion pair high-performance liquid chromatography-mass spectrometry1 , 2010, Journal of Lipid Research.
[4] E. Schon,et al. Modulation of mitochondrial protein phosphorylation by soluble adenylyl cyclase ameliorates cytochrome oxidase defects , 2009, EMBO molecular medicine.
[5] R. Acín-Pérez,et al. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. , 2009, Cell metabolism.
[6] J. Vonck,et al. Supramolecular organization of protein complexes in the mitochondrial inner membrane. , 2009, Biochimica et biophysica acta.
[7] J. Enríquez,et al. Respiratory active mitochondrial supercomplexes. , 2008, Molecular cell.
[8] K. Marcus,et al. Phosphorylation and Kinetics of Mammalian Cytochrome c Oxidase* , 2008, Molecular & Cellular Proteomics.
[9] William Stanley,et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation , 2008, Cardiovascular research.
[10] R. Margreiter,et al. Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells , 2008, Nature Protocols.
[11] Albert Sickmann,et al. Profiling Phosphoproteins of Yeast Mitochondria Reveals a Role of Phosphorylation in Assembly of the ATP Synthase*S , 2007, Molecular & Cellular Proteomics.
[12] N. Dencher,et al. Three-dimensional structure of the respiratory chain supercomplex I1III2IV1 from bovine heart mitochondria. , 2007, Biochemistry.
[13] R. Murphy,et al. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure Published, JLR Papers in Press, April 10, 2007. , 2007, Journal of Lipid Research.
[14] D. Galati,et al. Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/reperfusion , 2007, FEBS letters.
[15] M. Lazarou,et al. Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients. , 2006, Journal of molecular biology.
[16] Laura C. Greaves,et al. Mitochondrial DNA mutations in human disease , 2006, IUBMB life.
[17] S. Srinivasan,et al. Protein Kinase A-mediated Phosphorylation Modulates Cytochrome c Oxidase Function and Augments Hypoxia and Myocardial Ischemia-related Injury* , 2006, Journal of Biological Chemistry.
[18] S. Weintraub,et al. Photolabeling of cardiolipin binding subunits within bovine heart cytochrome c oxidase. , 2006, Biochemistry.
[19] R. Hetzer,et al. An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy , 2006, European journal of heart failure.
[20] J. Dixon,et al. Mitochondrial modulation: reversible phosphorylation takes center stage? , 2006, Trends in biochemical sciences.
[21] H. Schägger,et al. Blue native PAGE , 2006, Nature Protocols.
[22] Eric J. Murphy,et al. Mitochondrial Lipid Abnormality and Electron Transport Chain Impairment in Mice Lacking α-Synuclein , 2005, Molecular and Cellular Biology.
[23] P. Rehling,et al. Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth Syndrome. , 2005, Molecular biology of the cell.
[24] Jesse R. Dixon,et al. Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic beta cells. , 2005, Molecular cell.
[25] R. Murphy,et al. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M500031-JLR200 , 2005, Journal of Lipid Research.
[26] Robert W. Taylor,et al. Mitochondrial DNA mutations in human disease , 2005, Nature Reviews Genetics.
[27] S. Ficarro,et al. cAMP-dependent Tyrosine Phosphorylation of Subunit I Inhibits Cytochrome c Oxidase Activity* , 2005, Journal of Biological Chemistry.
[28] Xiaodong Cheng,et al. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Hoppel,et al. Blockade of Electron Transport during Ischemia Protects Cardiac Mitochondria* , 2004, Journal of Biological Chemistry.
[30] M. Chandler,et al. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. , 2004, American journal of physiology. Heart and circulatory physiology.
[31] T. Slabe,et al. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. , 2004, American journal of physiology. Heart and circulatory physiology.
[32] Icksoo Lee,et al. Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase , 2002, Molecular and Cellular Biochemistry.
[33] Kathy Pfeiffer,et al. Cardiolipin Stabilizes Respiratory Chain Supercomplexes* , 2003, Journal of Biological Chemistry.
[34] L. Cardone,et al. Essential Role of A-kinase Anchor Protein 121 for cAMP Signaling to Mitochondria* , 2003, The Journal of Biological Chemistry.
[35] M. Chandler,et al. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. , 2002, Journal of cardiac failure.
[36] William Dowhan,et al. Gluing the Respiratory Chain Together , 2002, The Journal of Biological Chemistry.
[37] L. Cardone,et al. A-kinase anchor protein 84/121 are targeted to mitochondria and mitotic spindles by overlapping amino-terminal motifs. , 2002, Journal of molecular biology.
[38] B. Robinson,et al. Control of oxygen free radical formation from mitochondrial complex I: roles for protein kinase A and pyruvate dehydrogenase kinase. , 2002, Free radical biology & medicine.
[39] A. Signorile,et al. Serine (threonine) phosphatase(s) acting on cAMP‐dependent phosphoproteins in mammalian mitochondria , 2002, FEBS letters.
[40] P. Kinnunen,et al. Phospholipid-Cytochrome c Interaction EVIDENCE FOR THE EXTENDED LIPID ANCHORAGE* , 2002 .
[41] N. Silverman,et al. Abnormal mitochondrial respiration in failed human myocardium. , 2000, Journal of molecular and cellular cardiology.
[42] C. Hoppel,et al. Separation and quantitation of phospholipids and lysophospholipids by high-performance liquid chromatography. , 2000, Analytical biochemistry.
[43] M. L. Greenberg,et al. The biosynthesis and functional role of cardiolipin. , 2000, Progress in lipid research.
[44] K. Pfeiffer,et al. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria , 2000, The EMBO journal.
[45] Ò. Miró,et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. , 2000, Cardiovascular research.
[46] B. Kadenbach,et al. The allosteric ATP‐inhibition of cytochrome c oxidase activity is reversibly switched on by cAMP‐dependent phosphorylation , 2000, FEBS letters.
[47] A. Matsuno-Yagi,et al. The NDUFA1 gene product (MWFE protein) is essential for activity of complex I in mammalian mitochondria. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Lesch,et al. Abnormal mitochondrial function in myocardium of dogs with chronic heart failure. , 1998, Journal of molecular and cellular cardiology.
[49] A. Kiersztan,et al. Inhibitory effect of vanadium compounds on glutamate dehydrogenase activity in mitochondria and hepatocytes isolated from rabbit liver. , 1998, Pharmacology & toxicology.
[50] F. L. Hoch. Cardiolipins and mitochondrial proton-selective leakage. , 1998, Journal of bioenergetics and biomembranes.
[51] C. Rubin,et al. Organelle-specific Targeting of Protein Kinase AII (PKAII) , 1997, The Journal of Biological Chemistry.
[52] G. Paradies,et al. Cardiolipin-dependent decrease of cytochrome c oxidase activity in heart mitochondria from hypothyroid rats. , 1997, Biochimica et biophysica acta.
[53] K. Beyer,et al. Specific cardiolipin binding interferes with labeling of sulfhydryl residues in the adenosine diphosphate/adenosine triphosphate carrier protein from beef heart mitochondria. , 1996, Biochemistry.
[54] S. Papa,et al. Topology of the mitochondrial cAMP‐dependent protein kinase and its substrates , 1996, FEBS letters.
[55] J. Bailey,et al. Isolation, mapping, and genomic structure of an X-linked gene for a subunit of human mitochondrial complex I. , 1996, Genomics.
[56] S. Papa,et al. The nuclear‐encoded 18 kDa (IP) AQDQ subunit of bovine heart complex I is phosphorylated by the mitochondrial cAMP‐dependent protein kinase , 1996, FEBS letters.
[57] S. Papa,et al. Characterization of proteins phosphorylated by the cAMP‐dependent protein kinase of bovine heart mitochondria , 1995, FEBS letters.
[58] A. Sanbe,et al. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. , 1995, Journal of molecular and cellular cardiology.
[59] N. Mons,et al. Adenylyl cyclases and the interaction between calcium and cAMP signalling , 1995, Nature.
[60] S. Papa,et al. cAMP‐dependent protein phosphorylation in mitochondria of bovine heart , 1994, FEBS letters.
[61] C. Hoppel,et al. Method for isolation of non-esterified fatty acids and several other classes of plasma lipids by column chromatography on silica gel. , 1993, Journal of chromatography.
[62] S. Papa,et al. Phosphorylation of mitochondrial proteins in bovine heart , 1993, FEBS letters.
[63] N. C. Robinson,et al. Functional binding of cardiolipin to cytochromec oxidase , 1993, Journal of bioenergetics and biomembranes.
[64] F. L. Hoch. Cardiolipins and biomembrane function. , 1992, Biochimica et biophysica acta.
[65] J. Křivánek,et al. A novel effect of vanadium ions: inhibition of succinyl-CoA synthetase. , 1991, General physiology and biophysics.
[66] B. Trinczek,et al. Localization of catalytic and regulatory subunits of cyclic AMP-dependent protein kinases in mitochondria from various rat tissues. , 1990, The Biochemical journal.
[67] D. Kerr,et al. Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. Fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy. , 1987, The Journal of clinical investigation.
[68] A. Azzi,et al. The monocarboxylate carrier from bovine heart mitochondria: partial purification and its substrate-transporting properties in a reconstituted system. , 1986, Biochimica et biophysica acta.
[69] D. E. Green,et al. Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. , 1980, Biochemical and biophysical research communications.
[70] C. Hoppel,et al. Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. , 1979, The Journal of biological chemistry.
[71] C. Hoppel,et al. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. , 1977, The Journal of biological chemistry.
[72] Skulachev Vp. Mechanism of oxidative phosphorylation and general principles of bioenergetics , 1974 .
[73] V. Skulachev. [Mechanism of oxidative phosphorylation and general principles of bioenergetics]. , 1974, Uspekhi sovremennoi biologii.
[74] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.
[75] B. Chance,et al. A Method for the Localization of Sites for Oxidative Phosphorylation , 1955, Nature.
[76] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.